Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluating management of treatment-naive primary cutaneous melanoma in elderly patients is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Cutaneous Melanoma | Phase 3 | Status: NOT_YET_RECRUITING